UCSF Helen Diller Family Comprehensive Cancer Center
member announcement for 2/10/2014
[ view online | correct or unsubscribe ]

Notes/News | This Week | Funding Opps | Abstracts/Nominations | Misc

Notes and News

UCSF Resource Allocation Program (RAP) invites applications for the Spring 2014 Cycle
  • Pilot for Established Investigators in Basic and Clinical/Translational Sciences
    Award Amount: $37,500
    These pilot projects are intended to support a wide range of biomedical research, including fundamental basic science, clinical/translational science, health policy and social science, and population science. Pilot projects are for one year and not renewable. Pilot research should collect data for publications and to acquire successful subsequent funding by other mechanisms.
  • Pilot for Junior Investigators in Basic and Clinical/Translational Sciences
    Award Amount: $37,500
    These pilot projects are intended to support a wide range of biomedical research, including fundamental basic science, clinical/translational science, health policy and social science, and population science. Pilot projects are for one year and not renewable.
  • Pilot - Informing Tobacco Product Regulation (New)
    Award Amount: $40,000
    The TCORS award provides money that we can award to faculty and senior postdoctoral fellows with innovative research ideas to expand or deepen the reach of our existing TCORS center. Pilot awards are typically used: (1) to initiate a project or (2) to gather preliminary data that will lead to a larger research project or (3) to quickly develop findings that will inform the FDA Center for Tobacco Products in regulation of the manufacture, marketing, and distribution of tobacco products in order to reduce the public health toll from tobacco product use in the United States. The current FDA Center for Tobacco Products (CTP) research interest areas are listed at http://prevention.nih.gov/tobacco/research.aspx; projects are not, however, limited to these specific areas so long as there is a clear connection to informing FDA regulatory and educational decisions on tobacco.
  • CC-AMC Pilot Awards in HIV-Associated Malignancies
    Award Amount: $50,000 - $100,000
    The focus of the awards program is to stimulate research collaborations on HIV-associated malignancies between investigators at the Helen Diller Family Comprehensive Cancer Center (HDFCCC) and NCI-supported AIDS Malignancy Consortium (AMC) investigators at UCSF by providing pilot funding to HDFCCC investigators. The purpose of the NCI supplemental funds is to foster pilot projects within the HDFCCC that have the potential to develop into larger independent research projects funded by the NIH or other organizations.
  • Team Science Grant (New)
    Award Amount: $50,000 - $75,000
    This program will provide funds for a "Team Science" grant. The goal of this award is to stimulate new collaborations of UCSF scientists from diverse fields, including social, basic, and clinical research, which address clinical and translational research questions that require an innovative, multidisciplinary approach. This award will provide funding to develop complex cross-disciplinary research projects, including arranging meetings of investigators, performing preliminary studies and preparing grant applications. In addition, we encourage teams that are diverse based on gender, ethnicity, race and other characteristics. ** Note: This is different from the HDFCCC T3 Award which will be offered separately later this year.
  • Catalyst Awards for the Development of Diagnostics, Devices, Therapeutics and Digital Health
    Up to $100,000 (or up to $30,000 for Digital Health)
E-submission deadline: Monday, February 24, 2014, 2 pm    >get more info

Events This Week

Funding Opportunities

Deadline: Feb 18
Damon Runyon Cancer Research Foundation: Clinical Investigator Award
They have changed the application process for 2014 and no longer require institutional nominations.

LOI Due: Feb 19
BD2K-LINCS-Perturbation Data Coordination and Integration Center (DCIC) (U54)

LOI Deadline: Feb 21
AVON Breast Cancer Safety Net
Up to $100,000 total costs.

Deadline: Feb 24
UCSF Resource Allocation Program (RAP) invites applications for the Spring 2014 Cycle

LOI Deadline: Feb 25
Using Social Media to Understand and Address Substance Use and Addiction (R01)

LOI Deadline: Feb 25
Using Social Media to Understand and Address Substance Use and Addiction (R21)

LOI Deadline: extended to March 2
NIH National Research Mentoring Network (NRMN) (U54)

Deadline: March 14
CTCP - CG 14-10013 Make Tobacco History

Deadline: April 1
Mentored Career Development Award in Biomedical Big Data Science for Clinicians and Doctorally Prepared Scientists (K01)

Deadline: April 1
Courses for Skills Development in Biomedical Big Data Science (R25)

Deadline: April 1
Open Educational Resources for Biomedical Big Data (R25)

Deadline: April 5
Direct Phase II SBIR Grants to Support Biomedical Technology Development

Deadline May/June 2014
NCI: Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control

Deadline: June 3
2015 Howard Hughes Medical Institute Investigator Competition

Cite HDFCCC!
Please help us continue our support of clinical & translational research. Publications supported by the CCSG grant in any way are required to credit the CCSG grant and comply with NIH Public Access Policy.

Abstracts/Posters/Nominations:

Resources:

  • Space@UCSF - information about office and work space at UCSF, including current renovation and construction projects
  • The Cancer Letter: Feb 7
    Reminder: The Cancer Letter is viewable by all HDFCCC members and lab staff and can be viewed by clicking the 'login by IP address' link. So long as you are logged into VPN or at a UCSF campus you can view the document.

UCSF-HDFCCC Karen Gehrman, Communications Manager
415.353.4471 (voice) | communications@cc.ucsf.edu




CONFIDENTIALITY NOTICE: This communication and any attachments may contain confidential and privileged information for the use of the designated recipient/s named above. Distribution, reproduction or any other use of this transmission by any party other than the intended recipient/s is prohibited.